National Health Investors (WX6) Stock Forecast & Price Target
WX6 Analyst Ratings
Strong Buy
5Buy1Hold0Sell
Based on 6 analysts giving stock ratings to National Health Investors in the past 3 months
WX6 Stock 12 Month Forecast
Average Price Target
EUR 71.73▲(28.10% Upside)Based on 6 Wall Street analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is EUR 71.73 with a high forecast of EUR 80.20 and a low forecast of EUR 60.60. The average price target represents a 28.10% change from the last price of EUR 56.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 80.20
AverageEUR 71.73
LowEUR 60.60
Highest Price TargetHighestEUR 80.20Average Price TargetEUR 71.73Lowest Price TargetLowestEUR 60.60
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Kilichowski | Wells Fargo | EUR 69.51→EUR 60.60 | hold | 8.21%Upside | Assigned | 10/19/26 | ||
| Juan C. Sanabria | BMO Capital | EUR 71.29 | buy | 27.30%Upside | Reiterated | 10/05/26 | ||
| Robert Stevenson | Janney Montgomery | EUR 70.40 | buy | 25.71%Upside | Initiated | 09/09/26 | ||
| Michael Lewis | Truist Financial | EUR 72.18→EUR 71.29 | buy | 27.30%Upside | Reiterated | 09/02/26 | ||
| Farrell Granath | Bank of America Securities | EUR 81.09→EUR 76.64 | buy | 36.85%Upside | Reiterated | 08/24/26 | ||
| Richard Anderson | Cantor Fitzgerald | EUR 80.20 | buy | 43.21%Upside | Reiterated | 08/14/26 | ||
| Omotayo Okusanya | Deutsche Bank | EUR 75.74→EUR 71.29 | hold | 27.30%Upside | Reiterated | 06/25/26 | ||
 Unknown AnalystNot Ranked | Jefferies | EUR 68.62 | hold | 22.53%Upside | Reiterated | 12/15/25 | ||
| Austin Wurschmidt | KeyBanc | EUR 71.29→EUR 78.42 | buy | 40.03%Upside | Reiterated | 12/04/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Kilichowski | 10/19/26 | EUR 69.51→EUR 60.60 | hold | 8.21%Upside | Assigned | Wells Fargo | ||
| Juan C. Sanabria | 10/05/26 | EUR 71.29 | buy | 27.30%Upside | Reiterated | BMO Capital | ||
| Robert Stevenson | 09/09/26 | EUR 70.40 | buy | 25.71%Upside | Initiated | Janney Montgomery | ||
| Michael Lewis | 09/02/26 | EUR 72.18→EUR 71.29 | buy | 27.30%Upside | Reiterated | Truist Financial | ||
| Farrell Granath | 08/24/26 | EUR 81.09→EUR 76.64 | buy | 36.85%Upside | Reiterated | Bank of America Securities | ||
| Richard Anderson | 08/14/26 | EUR 80.20 | buy | 43.21%Upside | Reiterated | Cantor Fitzgerald | ||
| Omotayo Okusanya | 06/25/26 | EUR 75.74→EUR 71.29 | hold | 27.30%Upside | Reiterated | Deutsche Bank | ||
| Unknown AnalystNot Ranked | 12/15/25 | EUR 68.62 | hold | 22.53%Upside | Reiterated | Jefferies | ||
| Austin Wurschmidt | 12/04/25 | EUR 71.29→EUR 78.42 | buy | 40.03%Upside | Reiterated | KeyBanc |
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
Best Analysts Covering National Health Investors
3 Months
Success Rate4/6 ratings generated profit
67%
Average Return
+5.43%
Copying Richard Anderson's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +5.43% per trade.
1 Year
Success Rate13/20 ratings generated profit
65%
Average Return
+5.67%
Copying Juan C. Sanabria's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +5.67% per trade.
2 Years
Success Rate8/20 ratings generated profit
40%
Average Return
+4.04%
Copying Juan C. Sanabria's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of +4.04% per trade.
WX6 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 6 | 6 | 6 | 7 |
| Hold | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 8 | 9 | 9 | 10 |
In the current month, WX6 has received 7 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. WX6 average Analyst price target in the past 3 months is 71.73.
WX6 Financial Forecast
HighEUR 1.73
ConsensusEUR 1.06
LowEUR 0.59
WX6 Earnings Forecast
Next quarter’s earnings estimate for WX6 is EUR 1.06 with a range of EUR 0.59 to EUR 1.73. The previous quarter’s EPS was EUR 1.03. Its overall industry beat the EPS estimate 54.52% of the time in the past 12 months.
HighEUR 64.3M
ConsensusEUR 61.4M
LowEUR 53.3M
WX6 Sales Forecast
Next quarter’s sales forecast for WX6 is EUR 61.36M with a range of EUR 53.34M to EUR 64.31M. The previous quarter’s sales results were EUR 109.38M. Its overall industry beat sales estimates 73.09% of the time in the past 12 months.
WX6 Stock Forecast FAQ
What is DE:WX6’s average 12-month price target, according to analysts?
Based on analyst ratings, National Health Investors’s 12-month average price target is €71.73.
What is DE:WX6’s upside potential, based on the analysts’ average price target?
National Health Investors has 28.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is National Health Investors a Buy, Sell or Hold?
National Health Investors has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is National Health Investors’s share price target?
The average share price target for National Health Investors is €71.73. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €80.20, and the lowest forecast is €60.60. The average share price target represents a 28.10% increase from the current price of €56.
What do analysts say about National Health Investors?
National Health Investors’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of National Health Investors?
To buy shares of DE:WX6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
